Back Home Search

Esophageal/GEJ/Gastric

    • Protocols
    • UW19029

      OPEN TO ACCRUAL

      P2- 5FU, oxaliplatin, nal-IRI & immunotherapy (+ trastuzumab for HER2+) for adv esophageal & gastric

    • S2303

      OPEN TO ACCRUAL

      Adding Nivolumab to Usual Treatment for People with Advanced Stomach or Esophageal Cancer

    • UW24158

      OPEN TO ACCRUAL

      P2 Safety & Efficacy of Raludotatug Deruxtecan Participants With GI Cancers